Podchaser Logo
Home
BIOtechNow

Biotechnology Industry Organization

BIOtechNow

A daily Science, Medicine and Technology podcast
Good podcast? Give it some love!
BIOtechNow

Biotechnology Industry Organization

BIOtechNow

Episodes
BIOtechNow

Biotechnology Industry Organization

BIOtechNow

A daily Science, Medicine and Technology podcast
Good podcast? Give it some love!
Rate Podcast

Episodes of BIOtechNow

Mark All
Search Episodes...
In a story entitled, “CMS Blames Medicare Part B Hikes on Drug Costs,” writers for Politico Pulse note:“The agency [Centers for Medicare & Medicaid Services] on Friday announced a $9 monthly premium increase and $13 annual deductible hike, but
Supporters of Speaker Pelosi’s drug pricing plan (H.R. 3) claim the bill will discourage the development of so-called “me too” drugs. For example, Rep. Donna Shalala was recently quoted as saying: “I think it actually will reduce me-too drugs
Alzheimer’s is one of the most feared diseases in the world. Despite many attempts to find an effective therapy to prevent or delay its effects, the disease remains largely untreatable. Many of us know someone with Alzheimer’s. For me, it was m
The Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce is set to examine the U.S. patent system this morning. Ahead of the hearing – and in honor of #ThrowBackThursay – we are resurfacing a piece by BIO’s T
The Trump Administration is moving forward with a plan to import foreign price controls into Medicare. Under the proposed International Pricing Index (IPI) model, the federal government would move away from a long-standing market-based reimburs
Whether you come to the Bay Area for the entrepreneurial talent, venture capital investment or biotech innovation, this trifecta conjures the perfect storm for regional economic success.The enduring strength of the Northern California life sci
As the biopharma industry has gained traction on new drug approvals throughout 2019, the financial dollars have followed suit.  According to BIO’s 2019 Emerging Therapeutic Company Trend Report, a record $17.5 billion in venture investment doll
The Biotechnology Innovation Organization (BIO), leading scientists, public policy experts, and industry leaders today announced the launch of “Working to Fight AMR,” a coalition working to raise public awareness of the growing threat posed by
We know that people have a lot of questions about GMOs. In fact, that’s exactly why the GMO Answers website and program was started. But we also know that people have a lot of questions about where their food comes from in general: how modern a
Experts recently gathered on Capitol Hill to discuss how importing foreign price controls will lead to less innovation and less patient access to breakthrough treatments. Leaders in biotech innovation, as well as within the patient community, h
In a recent study published by Tufts University, researchers found that rare disease drug development is now one of the fastest growing areas in drug R&D, with nearly one-third of all products in the global R&D pipeline targeting treatments for
Tomorrow, biotech breakthroughs—such as biofuels that reduce carbon pollution, biodegradable plastics made from plants, or gene-edited crops that can withstand and mitigate the effects of climate change—will take center stage in Des Moines for
In today’s increasingly connected world, health care researchers have access to previously unimaginable troves of data about the effects of healthcare interventions, including medicines. New technologies are allowing researchers to use so-calle
Congressman Stiver Continues Call for Sensible Patent ReformWhile there is consensus across Capitol Hill that patent reform legislation is badly needed, the path to achieving a broadly supported bill remains elusive. This is clearly no easy ta
Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property, recently testified at the second of three hearings in the Intellectual Property Subcommittee of the Senate Judiciary Committee on the subject of “The State of Patent Eligibilit
Last week, GMO Answers had a booth at Nutrition 2019, the annual scientific meeting of the American Society for Nutrition.  We had a lot of great conversations with registered dietitians, academics, food scientists, and others interested in foo
Just moments after it was announced the FDA had approved a new treatment for spinal muscular atrophy, Dr. Peter Bach was warning about a “break down” in the U.S. drug pricing system. It’s unfortunate Dr. Bach would respond to the discovery of a
As the biotechnology industry becomes more global, companies must evaluate and adopt various cross-border strategic models to drive capital formation and growth.Reforms within China affecting the biomedical industry, such as the accelerated re
This is an exciting time in biomedical innovation. New and highly innovative therapies are coming to market that promise significant improvements in patient health. They include a range of novel approaches to treating disease, like gene therapy
While health care conversations on Capitol Hill today are largely focused on how to best lower overall and patient out-of-pocket spending, one area of focus that could have tremendous societal and personal implications in the coming years is un
It took the sequencing of one genome, for a disease that used to mean a death sentence to become treatable and preventable. In 1984, scientists successfully sequenced the entire genome of the HIV virus, a critical first step to understanding an
Recently, I was asked to be on a panel on food and farming by a community college near my home outside of Washington, D.C. The symposium, designed for both farmers and the public, was called, “Food, Farmers, and Community: Opening the Dialogue,
There’s so much going on at the BIO International Convention each year that it can be hard to keep track of all the networking receptions, parties, and happy hours surrounding the Convention. To help you plan your experience in Philadelphia thi
The Biotechnology Innovation Organization (BIO) this week lauded an administration proposal that would be a significant step forward in passing along  savings from drugmakers’ rebates to beneficiaries enrolled in the Medicare drug benefit progr
In case you missed it, the 2019 BIO World Congress on Industrial Biotechnology is headed to Des Moines, Iowa, July 8-11, 2019!In addition to bringing the world’s largest conference on industrial biotechnology to a new region and city, #BIOWC19
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features